Cancer of Liver
27
2
5
12
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.4%
2 terminated out of 27 trials
85.7%
-0.8% vs benchmark
7%
2 trials in Phase 3/4
17%
2 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (27)
Getting To Implementation: Improving Cancer Screening for Veterans
Onco-primary Care Networking to Support TEAM-based Care
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prospective Cohort of Patients With Hepatocellular Carcinoma in France
Tempus Priority Study: A Pan-tumor Observational Study
Wet Heparinized Suction for Abdominal Cancer
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)
Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma
Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer
Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma
Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer
Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular Carcinoma
Low-dose Y90 Treatment Planning for HCC
Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors
Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)
Drug-loadable(T-ACE Beads)for Hepatoma Embolization Therapy
Taiwan ACE Beads for Hepatoma Embolization Therapy
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies